No abstract available
MeSH terms
-
COVID-19*
-
Dimethyl Fumarate / therapeutic use
-
Fingolimod Hydrochloride
-
Humans
-
Immunosuppressive Agents / adverse effects
-
Multiple Sclerosis* / drug therapy
-
Multiple Sclerosis, Relapsing-Remitting* / drug therapy
-
SARS-CoV-2
Substances
-
Immunosuppressive Agents
-
Dimethyl Fumarate
-
Fingolimod Hydrochloride